Literature DB >> 2212412

Increased serum IgE and increased prevalence of eosinophilia in 9-year-old children of smoking parents.

R Ronchetti1, F Macri, G Ciofetta, L Indinnimeo, R Cutrera, E Bonci, G Antognoni, F D Martinez.   

Abstract

We studied the relationship of serum IgE levels and eosinophil counts with passive smoking in 9-year-old, nonselected children from three Italian towns near Rome. Male children of smoking parents had a significantly higher total count and percentage of eosinophils (p = 0.008) and higher IgE levels (p = 0.01) than male children of nonsmoking parents. Prevalence of eosinophilia (defined as greater than or equal to 4% of total white blood cell count) was significantly correlated with the number of cigarettes smoked by parents among boys (p = 0.003) but not among girls (p = 0.20). There was a significant trend (p = 0.008) for prevalence of eosinophilia to increase with increasing levels of serum IgE. For any given level of serum IgE, the frequency of eosinophilia was higher among children of smoking parents than among children of nonsmoking parents. When parental smoking was studied in a multivariable analysis and after controlling for the other variable, it was still significantly associated with eosinophilia in the children of these smoking parents but not with serum IgE levels. We conclude that parental smoking is associated with a significant enhancement of the expression of the most important markers of allergic sensitization in the children of smoking parents. This is particularly evident for boys and may explain, at least in part, the increased frequency of respiratory symptoms in children of smoking parents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212412     DOI: 10.1016/s0091-6749(05)80104-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

1.  Enhanced allergic sensitisation related to parental smoking.

Authors:  R Ronchetti; E Bonci; R Cutrera; G De Castro; L Indinnimeo; F Midulla; G Tancredi; F D Martinez
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

2.  Bronchiolitis and asthma: are they related?

Authors:  L I Landau
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

3.  PPARγ agonist rosiglitazone prevents perinatal nicotine exposure-induced asthma in rat offspring.

Authors:  Jie Liu; Reiko Sakurai; E M O'Roark; Nicholas J Kenyon; John S Torday; Virender K Rehan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-02-25       Impact factor: 5.464

Review 4.  Health effects of passive smoking .5. Parental smoking and allergic sensitisation in children.

Authors:  D P Strachan; D G Cook
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

5.  IL-4 production is increased in cigarette smokers.

Authors:  K A Byron; G A Varigos; A M Wootton
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

6.  Changes in plasma IL4, TNFá and CRP in response to regular passive smoking at home among healthy school children in Khartoum, Sudan.

Authors:  T H Merghani; A Saeed; A Alawad
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

7.  Maternal smoking in pregnancy: do the effects on innate (toll-like receptor) function have implications for subsequent allergic disease?

Authors:  Susan L Prescott; Paul S Noakes
Journal:  Allergy Asthma Clin Immunol       Date:  2007-03-15       Impact factor: 3.406

8.  Bronchial responsiveness, eosinophilia, and short term exposure to air pollution.

Authors:  V Søyseth; J Kongerud; P Broen; P Lilleng; J Boe
Journal:  Arch Dis Child       Date:  1995-11       Impact factor: 3.791

Review 9.  [Influence of environmental factors on allergy development].

Authors:  W Schober; H Behrendt
Journal:  HNO       Date:  2008-08       Impact factor: 1.284

Review 10.  Update on allergies in pregnancy, lactation, and early childhood.

Authors:  Isabella Pali-Schöll; Harald Renz; Erika Jensen-Jarolim
Journal:  J Allergy Clin Immunol       Date:  2009-02-26       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.